RISS 학술연구정보서비스

검색

인기 검색어

    다국어 입력

    http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

    변환된 중국어를 복사하여 사용하시면 됩니다.

    예시)
    • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
    • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
    닫기

    miRNA 검출 및 유방암 진단을 위한 합금 금-니켈-금 자성막대 기반 CRISPR-SERS biosensor = CRISPR-Based SERS Biosensor Employing Alloy Au-Ni-Au Magnetic Rods for miRNA Detection and Breast Cancer Diagnosis

    한글로보기

    https://www.riss.kr/link?id=T17369871

    • 0

      상세조회
    • 0

      다운로드
    서지정보 열기
    • 내보내기
    • 내책장담기
    • 공유하기
    • 오류접수
    인용문이 복사되었습니다.

    부가정보

    다국어 초록 (Multilingual Abstract) kakao i 다국어 번역

    Breast cancer is one of the most common diseases and is the first cause of cancer-related deaths among women worldwide. Generally, late detection of breast cancer symptoms leads to higher mortality rates. Thus, early diagnosis of breast cancer is imperative to boost patient’s survival rate. Traditional diagnostic methods such as RT-qPCR take a long time, making it less suitable for on-site diagnosis.
    Herein, we developed a CRISPR-Based SERS biosensor for an early on-site diagnosis of breast cancer targeting miRNA-511, one of the biomarkers for breast cancer. The synergy of SERS and CRISPR/Cas technologies has further enhanced the selectivity and sensitivity of miRNA-511 detection. In this work, alloy gold-nickel-gold nanorods (Au-Ni-Au NRs) were first electrochemically deposited onto an anodic aluminum oxide (AAO) mask to be used as the nanomaterial probe. Consequently, CRISPR/Cas13 becomes activated upon its addition in the presence of target RNA via its binding to crRNA, allowing for a sensitive detection.
    Accordingly, leveraging the integration of CRISPR and SERS technologies, this study presents a biosensor capable of rapidly detecting breast cancer biomarkers on-site, removing the need for complex amplification steps and simplification on the experimental process. Therefore, our developed biosensor offers the potential for detecting other biomarkers beyond breast cancer disease that can be highly useful in developing countries and in field settings where medical infrastructures is limited.
    번역하기

    Breast cancer is one of the most common diseases and is the first cause of cancer-related deaths among women worldwide. Generally, late detection of breast cancer symptoms leads to higher mortality rates. Thus, early diagnosis of breast cancer is impe...

    Breast cancer is one of the most common diseases and is the first cause of cancer-related deaths among women worldwide. Generally, late detection of breast cancer symptoms leads to higher mortality rates. Thus, early diagnosis of breast cancer is imperative to boost patient’s survival rate. Traditional diagnostic methods such as RT-qPCR take a long time, making it less suitable for on-site diagnosis.
    Herein, we developed a CRISPR-Based SERS biosensor for an early on-site diagnosis of breast cancer targeting miRNA-511, one of the biomarkers for breast cancer. The synergy of SERS and CRISPR/Cas technologies has further enhanced the selectivity and sensitivity of miRNA-511 detection. In this work, alloy gold-nickel-gold nanorods (Au-Ni-Au NRs) were first electrochemically deposited onto an anodic aluminum oxide (AAO) mask to be used as the nanomaterial probe. Consequently, CRISPR/Cas13 becomes activated upon its addition in the presence of target RNA via its binding to crRNA, allowing for a sensitive detection.
    Accordingly, leveraging the integration of CRISPR and SERS technologies, this study presents a biosensor capable of rapidly detecting breast cancer biomarkers on-site, removing the need for complex amplification steps and simplification on the experimental process. Therefore, our developed biosensor offers the potential for detecting other biomarkers beyond breast cancer disease that can be highly useful in developing countries and in field settings where medical infrastructures is limited.

    더보기

    목차 (Table of Contents)

    • 1. INTRODUCTION 1
    • 1.1 Breast Cancer Detection 1
    • 1.2 MicroRNA (miRNA) 3
    • 1.3 Conventional methods for miRNA detection 4
    • 1.4 CRISPR Cas13 System 7
    • 1. INTRODUCTION 1
    • 1.1 Breast Cancer Detection 1
    • 1.2 MicroRNA (miRNA) 3
    • 1.3 Conventional methods for miRNA detection 4
    • 1.4 CRISPR Cas13 System 7
    • 1.5 Surface Enhanced Raman Scattering (SERS) 9
    • 1.6 Alloy Au-Ni-Au Magnetic Rods (Alloy Au-Ni-Au MRs) 11
    • 2. Materials and Methods 13
    • 2.1 Chemicals and Reagents 13
    • 2.2 Fabrication of Alloy Au-Ni-Au MRs 14
    • 2.3 Characterization of Alloy Au-Ni-Au MRs 15
    • 2.4 Working ability test 16
    • 2.5 CRISPR reaction optimization 17
    • 2.5.1 Coating concentration 17
    • 2.5.2 Coating time 17
    • 2.5.4 crRNA concentration 18
    • 2.5.5 CRISPR reaction time 18
    • 2.6 Performance evaluation 19
    • 2.6.1 Sensitivity test 19
    • 2.6.2 Selectivity test 19
    • 2.6.3 Clinical test 20
    • 3. Results and Discussion 21
    • 3.1 Experimental scheme 21
    • 3.2 Fabrication of Alloy Au-Ni-Au MRs 24
    • 3.3 Working ability test and CRISPR reaction optimization 29
    • 3.4 Performance evaluation 34
    • 3.4.1 Sensitivity test 34
    • 3.4.2 Selectivity test 35
    • 3.5 Clinical test 38
    • 4. Conclusion 42
    • Reference 44
    • 요약 56
    • List of Publications 58
    더보기

    분석정보

    View

    상세정보조회

    0

    Usage

    원문다운로드

    0

    대출신청

    0

    복사신청

    0

    EDDS신청

    0

    동일 주제 내 활용도 TOP

    더보기

    주제

    연도별 연구동향

    연도별 활용동향

    연관논문

    연구자 네트워크맵

    공동연구자 (7)

    유사연구자 (20) 활용도상위20명

    이 자료와 함께 이용한 RISS 자료

    나만을 위한 추천자료

    해외이동버튼